FRES Fresh2 Group Limited: Earnings growth forecast for next year
Fresh2 Group Limited's transition to B2B food supply has wiped out legacy assets, creating a fresh cash flow. Business resilience is driven by demand for staple products, while revenue stability relies on the volume of IT transactions within the food service industry. This EPS forecast chart visualizes the market consensus, where 0.00 determines the current value of the metric.
FRES (Fresh2 Group): analytical breakdowns and indicator data
- price and consensus price forecast:
- company stock capitalization data:
- book capitalization indicators:
- business debt structure and liquidity details:
Debt to Equity Fresh2 Group Limited|FRES - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Capital Fresh2 Group Ltd|FRES - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Fresh2 Group|FRES - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Fresh2 Group|Critical Liquidity fresh2.co
- net income and valuation ratios data:
FRES - Company Net Income|Expected Net Income Fresh2 Group Limited|FRES - Price to Earnings Ratio|Projected Price to Earnings Ratio Fresh2 Group Ltd|FRES - Price/Earnings to Growth Multiple|EV/EBITDA Multiple Fresh2 Group|FRES - Profit before payment of interest, taxes and amortization|Earnings per one share for the last 12 months Fresh2 Group|FRES - Net earnings per share for the last 12 months|Year-over-year earnings per one share growth for the last 12 months fresh2.co|FRES - Earnings per share growth in current year|Net earnings per share growth forecast for next year Fresh2 Group Limited
Fundamental company valuation:FRES, Fresh2 Group Limited
The efficiency of the Fresh2 Group Limited (FRES) B2B platform in optimizing supply chains and reducing costs for the food service industry is directly reflected in the EPS growth target for the coming year. This indicator measures the percentage change in expected earnings per share by aggregating analyst forecasts to assess future profitability, allowing investors to differentiate the business's fundamental potential from current market volatility.
Analysis of competing companies
Net earnings per share growth forecast for next year Agilent Tech|Quest Corp (DGX) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year ILMN|EXAS: Net earnings per share change forecast for next year|Net earnings per share growth forecast for next year Revvity RVTY|Expected earnings per share trend next year BIO|Anbio Tech - Earnings growth forecast for next year|Expected net earnings per share growth next year Nordion|QuidelOrtho (QDEL) - Net earnings per share growth forecast for next year|OPK - Consensus forecast of earnings per share growth for next year|CDNA (CareDx, Inc.) - Earnings growth forecast for next year|MRVI: Expected earnings per share trend next year|Net earnings per share growth forecast for next year Fulgent Corp (FLGT)|Expected earnings per share growth for next year Standard BioTools Corp LAB|Expected earnings per share trend next year Cytek Biosciences, Inc.|Earnings growth forecast for next year orasure.com OSUR|Net earnings per one share growth forecast for next year XGN|MDXH: Net earnings per share growth forecast for next year|Expected earnings per share trend next year Lucid Diagnostics Inc LUCD|PRE (Prenetics) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year IMDX (Insight Molecular Diagnostics, Inc.)|Expected earnings per share growth for next year Trinity Biotech Corp (TRIB)|Earnings growth forecast for next year PRPH|Net earnings per share growth forecast for next year AIMD (Ainos Inc)|Co-Diagnostics Corp (CODX) - Net earnings per share change forecast for next year|HSCS - Expected earnings per share growth for next year|Expected earnings per share trend next year Biomerica, Inc. (BMRA)|CDIO: Net earnings per share growth forecast for next year|Onconetix (ONCO) - Net earnings per share growth forecast for next year|Virax Biolabs Group Limited (VRAX) - Earnings growth forecast for next year|BJDX: Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year AWH|Expected earnings per share growth for next year AXDX (Accelerate Diagnostics)|Earnings growth forecast for next year CENTOGENE, N.V. (CNTG)|Consensus forecast of earnings per share growth for next year ENZ|GENE - Expected earnings per share growth for next year|Projected earnings per share increase next year 23andMe Inc. ME|PMD - Earnings growth forecast for next year
